首页> 外国专利> THERAPEUTIC AGENT USED FOR DIABETES OR DIABETIC COMPLICATION INCLUDING PROTEIN HAVING BIOLOGICAL ACTIVITY

THERAPEUTIC AGENT USED FOR DIABETES OR DIABETIC COMPLICATION INCLUDING PROTEIN HAVING BIOLOGICAL ACTIVITY

机译:用于糖尿病或糖尿病并发症(包括具有生物学活性的蛋白质)的治疗剂

摘要

PROBLEM TO BE SOLVED: To provide a new therapeutic agent for use in diabetes or diabetic complications.;SOLUTION: According to the present invention, there is provided a therapeutic agent used for diabetes or diabetic complications, the agent comprising Protein S or a protein having a 96% or more of homology with Protein S and biological activity equivalent thereto. Here, the diabetic complications include diabetic nephropathy, renal fibrosis, stroke, myocardial infarction, heart failure, peripheral vascular disorder and renal disorder, etc. The dosage form may be preferably selected from the group consisting of subcutaneous, intramuscular, intravenous, intrabronchial, intraperitoneal, intrahepatic, intrauterine, vaginal, rectal, buccal, sublingual, intranasal, and transdermal.;SELECTED DRAWING: Figure 16;COPYRIGHT: (C)2018,JPO&INPIT
机译:解决的问题:提供一种用于糖尿病或糖尿病并发症的新治疗剂。解决方案:根据本发明,提供一种用于糖尿病或糖尿病并发症的治疗剂,该治疗剂包含蛋白S或具有与蛋白质S的同源性为96%或更高,且其生物学活性相同。在此,糖尿病并发症包括糖尿病性肾病,肾纤维化,中风,心肌梗塞,心力衰竭,周围血管疾病和肾脏疾病等。剂型可优选选自皮下,肌内,静脉内,支气管内,腹膜内,肝内,子宫内,阴道,直肠,颊,舌下,鼻内和经皮。;部分附图:图16;版权:(C)2018,JPO&INPIT

著录项

  • 公开/公告号JP2017200890A

    专利类型

  • 公开/公告日2017-11-09

    原文格式PDF

  • 申请/专利权人 MIE UNIV;

    申请/专利号JP20160093222

  • 发明设计人 GABAZZA ESTEBAN;CORINA GABAZZA;

    申请日2016-05-06

  • 分类号A61K38/00;A61P3/10;A61P43/00;A61P13/12;A61P9/10;A61P9/04;A61P9/00;A61K45/00;C07K14/47;

  • 国家 JP

  • 入库时间 2022-08-21 13:59:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号